General approach to ventricular arrhythmias;Ventriküler Aritmilere Genel Yaklaşim

Anadolu Kardiyoloji Dergisi

Volumn 4, Issue 3, 2004, Pages 246-252

  Akar, Nihal ^a   Aydoǧdu, Sinan ^a   Diker, Erdem ^a  

^a Kardiyoloji Anabilim Dali ^*  (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; CISAPRIDE; ERYTHROMYCIN; KETOCONAZOLE; PHENOTHIAZINE; TERFENADINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMETHOPRIM;

ARTICLE; BRUGADA SYNDROME; CATECHOLAMINERGIC SYSTEM; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DEFIBRILLATOR; DRUG CLASSIFICATION; ELECTROCARDIOGRAPHY; HEART EJECTION FRACTION; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LONG QT SYNDROME; MORTALITY; QRS COMPLEX; TORSADE DES POINTES;

ANTI-ARRHYTHMIA AGENTS; DECISION TREES; HUMANS; TACHYCARDIA, VENTRICULAR;

EID: 4644301573     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Cardiac Arrhythmia Suppression Trial (CAST) Investigators: Preliminary report: Effect of encainide and flecainide on mortality in a randomised trial of arrhythmia supression after miyokardial infarction. N Engl Med 1989; 321: 406-12.
2. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide or placebo. The Cardiac Arrhythmia Supression Trial. N Engl J Med 1991; 324: 781-8.
3. Kostis JB, Allen R, Berkson DM, et al. Correlates of ventricular ectopic activity in isolated systolic hypertension. SHEP Cooperative Research Group. Am Heart J 1994; 127: 112-21.
4. Bigger JT, Wenger TL, Heissenbuttel RH: Limitations of Lown grading system for the study of human ventricular arrhythmias. Am Heart J 1977 ; 93: 727-31.
5. Kennedy HL, Whitlock JA, Spargue MK, et al. Long-term follow up of asymptomatic healty subjects with frequent and complex ventricular ectopy. N Engl J Med 1985; 312: 193-8.
6. Gaita F, Giustetto C, Di Donna P, et al. Long-term follow-up of right ventricular monomorphic extrasystoles. J Am Coll Cardiol 2001; 38: 364-70.
7. Krittayaphong R, Bhuripanyo K, Punlee K, Kangkagate C, Chaithiraphan S. Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease: A randomized placebo-controlled study. Am Heart J 2002; 144: A4-A10.
8. Vismera LA, Amsterdarn BA, Mason DT. Relation of ventricular arrhythmias in the late hospital phase of acute myocardial infarction to sudden death after hospital discharge. Am J Med 1975; 59: 6-12.
9. Bigger JT Jr. Relation between left ventricular dysfunction and ventricular arrhythmias after myocardial infarction. Am J Cardiol 1986; 57: 8B
10. Maggio AP, Zuanetti G, Franzoni G, et al. Prevalance and prognostic significance of ventricular arrhythmias after acute myocardial infarction in fibrinolitic era: GISSI-2. Circulation 1993; 87: 312-7.
11. Cairns JA, Connolly SJ, Roberts R, et al. Randomized trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarizations: CAMIAT. Lancet 1997; 349: 675-82.
12. Singh SN, Flecher RD, Fisher SG, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995; 333: 77-82.
13. Califf RM, McKinnis RA, Burke J, et al. Prognostic implications of ventricular arrhythmias during 24-hour ambulatory monitoring in patients undergoing cardiac catheterization for coronary disease. Am J Cardiol 1982; 50: 23-9.
14. McKenna WJ, Chetty S, Oakley CM, et al. Arrhythmia in hypertrophic cardiomyopathy: Exercise and 48 hour ambulatory electrocardiographic assasment with without beta adrenergic blocking therapy.Am J Cardiol 1980; 45: 1-5.
15. Spirito P, Seidman CE, McKenna WJ, et al. The management of hypertrophic cardiomyopathy. N Engl J Med 1997; 336: 775-85.
16. Fananapazir L, McAreavy D, Epstein ND. Hypertrophic cardiomyopathy. In: Zipes DP, Jalife J, editors. Cardiac Electrophysiology; From Cell to Bedside. 2nd ed. Philadelphia: WB Saunders; 1994. pp 769-79.
17. Watson RM, Schwartz JL, Maron BJ, et al. Inducible polymorphic ventricular tachycardia and ventricular fibrillation in a subgroup of patients with hypertrophic cardiomyopathy at high risk for sudden death. J Am Coll Cardiol 1987; 10: 761-6.
18. Fananazapir L, Epstein SE. Value of electrophysiologic studies in hypertrophic cardiomyopathy treated with amiodarone. Am J Cardiol 1991; 67: 175-9.
19. Maron BJ, Shen WK, Link MS, et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden cardiac death in patients with hypertrofic cardiomyopathy. N Engl J Med 2000; 342: 365-70.
20. Doval HC, Nul DR, Grancelli HO, et al. Nonsustained ventricular tachycardia in severe heart failure: independent marker of increased mortality due to sudden death. Circulation 1996; 94: 3198-203.
21. Gradman A, Deedwania P, Cody R, et al. Predictors of total mortality and sudden cardiac death in mild to moderate heart failure. J Am Coll Cardiol 1989; 14: 564-9.
22. Meinertz T, Treese N, Kasper W, et al. Determinants of prognosis in idiopathic dilated cardiomyopathy as determined by programmed stimulation. Am J Cardiol 1985; 56: 337-41.
23. Quing KA, Schaechter A, Anderson KP, et al. Defibrillators in nonischemic cardiomyopathy. Am J Cardiol 1986; 57: 991-5.
24. De Soyza N, Bennett FA, Murphy ML, et al. The relationship of paroxysmal ventricular tachycardia complicating the acute phase and ventricular arrhythmia during the late hospital phase of acute infarction to long-term survival. Am J Med 1978; 64: 377-81.
25. Brodsky M, Wu D, Denes P, et al. Arrhythmia documented by 24 hour continuous electrocardiographic monitoring in 50 male medical students without apparent heart disease. Am J Cardiol 1977; 39: 390-5.
26. Cheema AN, Sheu K, Parker M, et al. Nonsustained ventricular tachycardia in the setting of acute myocardial infarction: tachycardia characteristics and their prognostic significance. Circulation 1998; 98: 2030-4.
27. Wilber DJ, Olshanski B, Moran JF, et al. Electrophysiologic testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function. Circulation 1990; 82: 350-8.
28. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996; 335: 1933-40.
29. Buxton AE, Lee KL, Fisher JD, et al. A randomized study of prevention of sudden cardiac death in patients with coronary artery disease. N Engl J Med 1999; 341: 1882-90.
30. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-83.
31. Part 6: Advanced Cardiovascular Life Support Section 7: Algorithm Approach to ACLS 7C: A Guide to the International ACLS Algorithms. Resuscitation 2000; 46: 169-84.
32. Tan HL, Lie KL. Prophylactic lidocaine use in acute myocardial infarction revisited in thrombolytic era. Am Heart J 1999; 137: 770-3.
33. Newby KH, Thompson T, Stebbins A, et al. Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: Incidence and outcomes. The GUSTO Investigators. Circulation 1998; 98: 2567-73.
34. Bigger JT Jr, Whang W, Rottman JN, et al. Mechanisms of death in the CABG Patch trial: A randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery. Circulation 1999; 99: 1416-21.
35. AVID investigators: a comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576-83.
36. Siebels J, Cappato R, Ruppel R, et al. Preliminary results of the Cardiac Arrest Study Hamburg (CASH). CASH Investigators. Am J Cardiol; 1993: 72(Suppl): 109F-113F.
37. Cappato R: Secondary prevention of sudden death: The Dutch Study, the Antiarrhythmics Versus Implantable Defibrillator Trial, the Cardiac Arrest Study Hamburg, and the Canadian Implantable Defibrillator Study. Am J Cardiol 1999; 83(Suppl): 68D-73D.
38. Gregorators G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE Guideline update for implantation of cardiac pacemakers and antiarrhythmia devices. Circulation 2002; 106: 2145-61.
39. Klein H, Auricchio A, Reek S, Geller C. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II. Am J Cardiol 1999;83: 91D-7D.
40. Miles WM. Idiopathic ventricular outflow tract tachycardia: where does it originate? J Cardiovasc Electrophysiol 2001; 12: 536-40.
41. Napolitano C, Priori SG. Genetics of ventricular tachycardia. Curr Opinion Cardiol 2002; 17: 222-8.
42. Gill JS, Blaszyk K, Ward DE, et al. Verapamil for the suppression of idiopathic ventricular tachycardia of LBBB-like morphology. Am Heart J 1993; 126: 1126-33.
43. Nakagawa H, Beckman KJ, McClelland JH, et al. Radiofrequency catheter ablation of idiopathic left ventricular tachycardia guided by a Purkinje potential. Circulation 1993; 88: 2607-17.
44. Priori SG, Napolitano C. Genetic of arrhythmogenic disorders. In: Podrid PJ, Kowey PR. editors, Cardiac Arrhythmia Mechanisms, Diagnosis and Management. 2rtd Philadelphia: Lippincott Williams & Wilkins; 2001: 81-107.
45. Schwartz PJ, Locati EH, Moss AJ, et al. Left cardiac sympathetic denervation in the therapy of congenital long QT syndrome: a worldwide report, Circulation 1991; 84: 503-11.
46. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death; a distinct clinical and electrocardiographic syndrome. A multicenter report.J Am Coll Cardiol 1992; 20: 1391-6.
47. Brugada J, Brugada P. Further characterization of syndrome of right bundle branch block, ST segment elevation, and sudden cardiac death.J Cardiovasc Electrophysiol 1997; 8: 325-31.
48. Leenhardt A, Lucet V, Denjoy A, et al: Catecholaminergic polymorphic ventricular tachycardia. Circulation 1995; 92: 421-9.
49. Martini B, Buja GF, Canciani B, et al. Bidirectional tachycardia. A sustained form, not related to digitalis intoxication,in an adult without apparent cardiac disease.Jpn Heart J 1988; 29: 381-7.